Biostar Pharmaceuticals (Biostar Pharmaceuticals) Accounts Payable & Accrued Expense : $2.69 Mil (As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Biostar Pharmaceuticals Accounts Payable & Accrued Expense?

Biostar Pharmaceuticals's quarterly accounts payable & accrued expense increased from Mar. 2017 ($2.53 Mil) to Jun. 2017 ($2.73 Mil) but then declined from Jun. 2017 ($2.73 Mil) to Sep. 2017 ($2.69 Mil).

Biostar Pharmaceuticals's annual accounts payable & accrued expense declined from Dec. 2014 ($5.43 Mil) to Dec. 2015 ($4.27 Mil) and declined from Dec. 2015 ($4.27 Mil) to Dec. 2016 ($2.84 Mil).

Biostar Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Biostar Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biostar Pharmaceuticals Accounts Payable & Accrued Expense Chart

Biostar Pharmaceuticals Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

6.36

4.79

5.43

4.27

2.84

Biostar Pharmaceuticals Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															4.10	2.84	2.53	2.73	2.69

Biostar Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biostar Pharmaceuticals Inc (OTCPK:BSPM) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 588 Shiji Xi Avenue, Shaanxi Province, Xianyang, CHN, 712046

Website

http://www.biostarpharmaceuticals.com

Biostar Pharmaceuticals Inc through its subsidiaries involves in the development, manufacturing, and marketing of pharmaceutical products for a variety of diseases and conditions in the People's Republic of China where it generates most of its revenues. The company's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. The current product line of the company also includes several other OTC products and approximately 15 prescription-based pharmaceuticals. Its products are derived from medicinal herbs that are either grown at its own facility or purchased from the suppliers.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Headlines

From GuruFocus

Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice

By PRNewswire PRNewswire • 04-23-2018

Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq

By Marketwired Marketwired • 08-23-2018